Lumexa Imaging Holdings, Inc. Common Stock

NASDAQ:LMRI

Medical - Devices

Healthcare
$14.01 +7.25%

+$0.84 today

Market cap
$1.35B
Beta
2.18
P/E (TTM)
-34.3
EPS (TTM)
-$0.28
52W Low $6.45High $19.45

Volume 0.26M

Average 0.92M

LMRI Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Lumexa Imaging Holdings, Inc. Common StockNASDAQ: LMRI

Net Margin · Q1 FY2026 · quarter ended Mar 2026

Net margin at 0.7%

Net margin was 0.7% in Q1 FY2026.

Context

  • Net margin widened in 2 of the last 2 fiscal years.
  • FY2025 was the highest level in the 3 fiscal years shown.

What to watch

Whether net margin reaches the consensus estimate from 7 analysts of 5.8% for the fiscal year ending Dec 2026, up from -4.6% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
0.7%+11.4 pp QoQ
Last fiscal yearDec 2025
-4.6%+5.3 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter———
1 year+5.3 pp+10.4 pp+5.1 pp
3 years—+11.0 pp—
5 years+12.2 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
-4.6%
Year-over-year change
+5.3pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How LMRI compares with its peers on the latest reported figures

  • LMRI's FY2025 net margin of -4.6% is the lowest of the 2 companies compared; the peer median is -0.9%.
  • Its year-over-year change of +5.3 pp is the highest of 2, against a peer median of -0.3 pp.
LMRI Competitors Peer median
Net Margin for LMRI and competitors
Company Period LTM level YoY 3-year change
RDNTRadNet, Inc.LTM Sep 2026-0.9% -0.3 pp-1.7 pp
LMRILumexa Imaging Holdings, Inc. Common StockFY2025-4.6% +5.3 pp—
Peer median (excluding LMRI) -0.9%-0.3 pp-1.7 pp

Competitors are the stored peer set for LMRI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue935.93M948.87M1.02B
Cost of Revenue836.96M852.61M905.9M
Gross Profit98.97M96.26M117.19M
Gross Margin10.6%10.1%11.5%
Research & Development000
Selling, General & Admin55.17M70.36M90.45M
Operating Expenses76.52M41.02M90.45M
Depreciation & Amortization72.14M57.16M55.39M
EBITDA94.58M114M141.71M
EBITDA Margin10.1%12.0%13.9%
Operating Income22.45M55.24M26.73M
Operating Margin2.4%5.8%2.6%
Interest Income000
Interest Expense141.69M136.03M118.54M
Other Income / Expenses(141.69M)(134.44M)(58.95M)
Income Before Tax(119.25M)(79.19M)(32.22M)
Pre-Tax Margin-12.7%-8.3%-3.1%
Income Tax Expense2.98M14.91M14.89M
Net Income(122.23M)(94.1M)(47.1M)
Net Margin-13.1%-9.9%-4.6%
EPS (Basic)(1.29)(1.00)(0.66)
EPS (Diluted)(1.29)(1.00)(0.66)
Weighted Avg Shares94.57M94.57M70.98M
Weighted Avg Shares (Diluted)94.57M94.57M70.98M

Lumexa Imaging Holdings, Inc. Common Stock

NASDAQ:LMRI

Intrinsic Alpha fair value

Locked

Current Price

$14.01

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.